Cantel Medical (Cantel Medical) EV-to-Revenue : 3.62 (As of Apr. 25, 2024)

View and export this data going back to 1992. Start your Free Trial

What is Cantel Medical EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Cantel Medical's enterprise value is $4,126 Mil. Cantel Medical's Revenue for the trailing twelve months (TTM) ended in Apr. 2021 was $1,138 Mil. Therefore, Cantel Medical's EV-to-Revenue for today is 3.62.

The historical rank and industry rank for Cantel Medical's EV-to-Revenue or its related term are showing as below:

CMD' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.04 Med: 3.64 Max: 6.55
Current: 3.57

During the past 13 years, the highest EV-to-Revenue of Cantel Medical was 6.55. The lowest was 1.04. And the median was 3.64.

CMD's EV-to-Revenue is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 3.07 vs CMD: 3.57

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-04-25), Cantel Medical's stock price is $80.37. Cantel Medical's Revenue per Share for the trailing twelve months (TTM) ended in Apr. 2021 was $25.95. Therefore, Cantel Medical's PS Ratio for today is 3.10.

Cantel Medical EV-to-Revenue Historical Data

The historical data trend for Cantel Medical's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cantel Medical EV-to-Revenue Chart

Cantel Medical Annual Data

Trend

Jul11

Jul12

Jul13

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

EV-to-Revenue

Get a 7-Day Free Trial

4.24

4.08

4.45

4.35

2.77

Cantel Medical Quarterly Data
	Jul16	Oct16	Jan17	Apr17	Jul17	Oct17	Jan18	Apr18	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21
EV-to-Revenue	Get a 7-Day Free Trial															2.46	2.77	2.58	3.67	3.83

Competitive Comparison of Cantel Medical's EV-to-Revenue

For the Medical Instruments & Supplies subindustry, Cantel Medical's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cantel Medical's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cantel Medical's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Cantel Medical's EV-to-Revenue falls into.

Cantel Medical EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Cantel Medical's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	4125.665	/	1138.391
	=	3.62

Cantel Medical's current Enterprise Value is $4,126 Mil.
Cantel Medical's Revenue for the trailing twelve months (TTM) ended in Apr. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,138 Mil.

Cantel Medical (NYSE:CMD) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Cantel Medical's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	80.37	/	25.947
	=	3.10

Cantel Medical's share price for today is $80.37.
Cantel Medical's Revenue per Share for the trailing twelve months (TTM) ended in Apr. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $25.95.

Cantel Medical EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Cantel Medical's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Cantel Medical (Cantel Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cantel Medical Corp (NYSE:CMD) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

150 Clove Road, 9th Floor, Little Falls, NJ, USA, 07424

Website

http://www.cantelmedical.com

Cantel Medical is a New Jersey-based manufacturer of hospital supplies for infection prevention, which include products used in endoscope disinfection, water purification systems for use in dialysis treatment, and dental supplies. The firm reports in four segments: medical (46% of fiscal 2020 sales), dental (32%), life sciences (19%), and dialysis (3%). Geographic exposure is primarily in the U.S., which accounts for about 75% of revenue, with international markets making up the remaining 25%.

Executives

Ann E Berman	director	255 STATE STREET, BOSTON MA 02109
Jeffrey Z Mann	officer: SVP, General Counsel	150 CLOVE ROAD, 9TH FLOOR, LITTLE FALLS NJ 07424
George L Fotiades	director, officer: Chief Executive Officer	281 SUMMIT AVENUE, SUMMIT NJ 07901
Charles M Diker	director, 10 percent owner, officer: Chairman	ONE NEW YORK PLAZA, NEW YORK NY 10004
Shaun M. Blakeman	officer: SVP - CFO	C/O CANTEL MEDICAL CORP., 150 CLOVE ROAD, LITTLE FALLS NJ 07424
Jean Casner	officer: SVP and CHRO	150 CLOVE ROAD, LITTLE FALLS NJ 07424
Brian Capone	officer: SVP and Princ. Accounting Ofr	150 CLOVE ROAD, 9TH FLOOR, LITTLE FALLS NJ 07424
Peter G Clifford	officer: President and COO	40 TOURNAMENT DRIVE SOUTH, HAWTHORN WOODS IL 60047
Seth M Yellin	officer: Executive Vice President	150 CLOVE ROAD 9TH FLOOR LITTLE FALLS NJ 07424
Laura L Forese	director	849 STONEWALL COURT FRANKLIN LAKES NJ 07417
Peter Pronovost	director	JHU-QSRG 1909 THAMES ST. - 2ND FLOOR BALTIMORE MD 21231
Anthony B Evnin	director	C/O VENROCK ASSOCIATES, 7 BRYANT PARK, 23RD FLOOR, NEW YORK NY 10018
Ronnie Myers	director	TOURO COLLEGE OF DENTAL MEDICINE 40 SUNSHINE COTTAGE ROAD VALHALLA NY 10595
Alan R Batkin	director	399 PARK AVENUE, 10TH FLOOR, NEW YORK NY 10022
Karen Prange	director	1108 S RIO VISTA BLVD, FORT LAUDERDALE FL 33316